Background: Chronic Hepatitis C virus (HCV) is a major public health concern and the leading chronic viral cause of death in the United States. Some estimates suggest that less than 50% of those infected with HCV are aware of their infection. Community-based testing strategies are needed, but uncertainty exists surrounding the implementation of HCV testing, linkage to care, and treatment. Methodology: We conducted a rapid testing and linkage to care program at urban community health centers and alcohol and drug treatment programs. HIV test counselors were cross-trained on HCV testing and counseling. Demographic and risk-factor data was collected prospectively. Rapid HCV Antibody testing was followed immediately by post-test counseling, phlebotomy for confirmatory viral load testing, and linkage to care. Results: Between 4/23/13 and 9/5/13 we conducted 453 rapid tests at 3 clinic sites and 6 residential alcohol and drug treatment programs. 94 rapid tests (21%) were positive. Of those patients with positive rapid HCV Ab tests, 12 (12.7%) refused confirmatory testing. 82 patients had confirmatory viral loads drawn with 59 (71.9%) positive and 23 (28%) undetectable indicating resolved infection. Of the 94 HCV Ab positive patients, 63 (67%) were male and 38 (40.4%) fell within the ‘baby boomer’ birth cohort of birth year between 1945-1965. 47 (50%) disclosed a prior history of injection drug use. The median age was 44 (range 22-64). Only 25 of 94 (26.5%) had insurance, and of these, all but 2 were publicly funded (Medicaid or Low Income health insurance). Overall, 67 (71.2%) were linked to care and one started treatment. Conclusions: This demonstration project reports a very high seroprevalence of HCV in urban community health centers and alcohol and drug rehabilitation centers. Many patients refused confirmatory blood draws, and only half reported prior injection drug use. Only one quarter of all HCV Ab positive patients had insurance at the time of testing, and of those who were insured, their plans would generally not cover HCV treatment. Stigma, denial, lack of healthcare insurance, and lack of coverage for HCV treatment are significant obstacles to the effort to address the HCV epidemic.